Prediction of central nervous system embryonal tumour outcome based on gene expression

Embryonal tumours of the central nervous system (CNS) represent a heterogeneous group of tumours about which little is known biologically, and whose diagnosis, on the basis of morphologic appearance alone, is controversial. Medulloblastomas, for example, are the most common malignant brain tumour of childhood, but their pathogenesis is unknown, their relationship to other embryonal CNS tumours is debated, and patients|[rsquo]| response to therapy is difficult to predict.

, , , , , , , , , , , , , , , , , , , , , , , &

To read this article in full you may need to log in, make a payment or gain access through a site license (see right).